About Us
About JRC
Our Team
Our Mission & Vision
Services
Integrated Product Development
Biotech & Pharma Business Development
Biotech Capital Support
Solutions
End-to-End Solutions for Global Biotech
Solution #1 – Global Licensing-Out to MNCs
Solution #2 – Cross-Regional Strategic In-Licensing
Solution #3 – China Market Entry for European & US Biotech
Solution #4 – 505(b)(2) & First-to-File Product Strategy
Solution #5 – Biotech Investment & Asset Incubation
Insights
Activities & Events
Activities
Events
Careers
Overview
Career Opportunities
Contact Us
English
中文
English
|
中文
About us
About JRC
Our Team
Our Mission & Vision
Services
Integrated Product Development
Biotech & Pharma Business Development
Biotech Capital Support
Solutions
End-to-End Solutions for Global Biotech
Solution #1 – Global Licensing-Out to MNCs
Solution #2 – Cross-Regional Strategic In-Licensing
Solution #3 – China Market Entry for European & US Biotech
Solution #4 – 505(b)(2) & First-to-File Product Strategy
Solution #5 – Biotech Investment & Asset Incubation
Insights
Activities & Events
Activities
Events
Careers
Contact us
Activities & Events
Activities & Events
Activities
Events
Activities
JRC COO Ms. Connie Shi with Dr. Ruyi He, Chief Scientist of Center for Drug Evaluation, NMPA
Founding partner, Gary Chu, with global medical project for ATM AGGIES fund
Investor Forum in Beijing
Management team meeting with main members of SAFE Investment
Jiangsu conference of Medical Alliance Development Forum
Shanxi conference of Medical Alliance Development Forum
Organizing alliance members to visit famous hospitals in Taiwan
CSRC Approval of M&A project of Everjoy Health Group (002162.SZ)
We look forwards to meeting with you in the events.
First
Prev
1
2
Last
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Read More
Accept
If you would like to get in touch with us, please click here.
Contact us
Request A Quote